Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Abstract

Our results suggest that the EGFR status of patients with NSCLC differs between patients 80 years or older and those younger than 80 years. EGFR mutation status might be a prognostic marker in elderly patients with completely resected NSCLC.